NanoMetalene

Spine

Josh SandbergDecember 18, 2019
560

SeaSpine Announces 25,000th NanoMetalene® Implantation

CARLSBAD, Calif., Dec. 18, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More »
Biologics

Chris J. StewartJuly 26, 2019
1,231

SeaSpine Announces 20,000th NanoMetalene® Implantation

CARLSBAD, Calif., July 26, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More »
Spine

DrueFebruary 2, 2017
1,658

SeaSpine® Announces Full Commercial Launch of Vu a∙POD™ Prime NanoMetalene® System

CARLSBAD, Calif., Jan. 31, 2017 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical…
Read More »
Spine

Josh SandbergJuly 5, 2016
891

SeaSpine Introduces Hollywood™ VI NanoMetalene® Interbody Device

CARLSBAD, Calif., June 15, 2016 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions…
Read More »
Spine

Josh SandbergAugust 12, 2015
1,393

SeaSpine Launches Ventura(TM) NanoMetalene(R) Interbody Device

VISTA, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for…
Read More »